Article
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
5 Oct 2021
Abstract excerpt
Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept efficacy testing of new drugs and vaccines. However, unlike Plasmodium falciparum, well-characterized P. vivax parasites that are safe and suitable for use in modern CHMI models are limited. Here, 2 healthy malaria-naive United Kingdom adults with universal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
